Dacomitinib

Back to search

Molecule Structure

Scientific Name

Dacomitinib

Description of the Drug

Dacomitinib is a medication used to treat non small cell lung cancer with EGFR exon 19 deletion of exon 21 L858R substitution.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11963

Brand Name(s)

Not Available

Company Owner(s)

Pfizer Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Epidermal growth factor receptor erbB1 SINGLE PROTEIN INHIBITOR CHEMBL203
Receptor protein-tyrosine kinase erbB-4 SINGLE PROTEIN INHIBITOR CHEMBL3009
Receptor protein-tyrosine kinase erbB-2 SINGLE PROTEIN INHIBITOR CHEMBL1824

Unichem Links

SureChEMBL SCHEMBL25637
DrugBank DB11963
PubChem: Thomson Pharma 16613030
PubChem 11511120
LINCS LSM-42808
Nikkaji J3.341.567B
PDBe 1C9
BindingDB 112499
EPA CompTox Dashboard DTXSID50149493
DrugCentral 5297
Brenda 213443
ChemicalBook CB22566418
Guide to Pharmacology 7422
rxnorm DACOMITINIB ANHYDROUS VIZIMPRO DACOMITINIB
ChEBI 132268
ZINC ZINC000072266312